UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended June 30, 2024 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from ______ to ______ Commission File Number: 001-12111 Pediatrix Medical Group, Inc. (Exact name of registrant as specified in its charter) Florida 26-3667538 (State or other ...

FOR MORE INFORMATION: Charles Lynch Senior Vice President, Finance and Strategy 954-384-0175, x 5692 charles.lynch@pediatrix.com FOR IMMEDIATE RELEASE Pediatrix Medical Group Reports Second Quarter Results FORT LAUDERDALE, Fla., August 6, 2024 - Pediatrix Medical Group, Inc. (NYSE: MD), a leading provider of physician services, today reported a loss of $1.84 per share for the three months ended June 30, 2024. On a non-GAAP basis, Pediatrix reported Adjusted EPS of $0.34. For the 2024 second quarter, Pediatr ...

A month has gone by since the last earnings report for Pediatrix Medical Group (MD) . Shares have lost about 15.9% in that time frame, underperforming the S&P 500. Will the recent negative trend continue leading up to its next earnings release, or is Pediatrix Medical Group due for a breakout? Before we dive into how investors and analysts have reacted as of late, let's take a quick look at the most recent earnings report in order to get a better handle on the important catalysts. Pediatrix Q1 Earnings Beat ...

Pediatrix Medical Group, Inc. (MD) reported first-quarter 2024 adjusted earnings per share (EPS) of 20 cents, which outpaced the Zacks Consensus Estimate by 11.1%.  However, the bottom line declined 13% year over year.Net revenues inched up 0.8% year over year to $495.1 million on the back of growth in same-unit revenues. Yet, the top line fell short of the consensus mark by a whisker.The quarterly results gained on the back of higher patient volumes and improved hospital contract administrative fees. Howev ...

Pediatrix Medical Group, Inc. (NYSE:MD) Q1 2024 Earnings Conference Call May 7, 2024 9:00 AM ET Company Participants Charles Lynch - SVP, Finance and Strategy James Swift - Chief Executive Officer Marc Richards - Executive Vice President and Chief Financial Officer Conference Call Participants Pito Chickering - Deutsche Bank Kevin Fischbeck - Bank of America Operator Ladies and gentlemen, thank you for standing by. Welcome to the Pediatrix Medical Group 2024 First Quarter Earnings Conference Call. At this t ...

Pediatrix Medical Group (MD) reported $495.1 million in revenue for the quarter ended March 2024, representing a year-over-year increase of 0.8%. EPS of $0.20 for the same period compares to $0.23 a year ago.The reported revenue represents a surprise of -0.23% over the Zacks Consensus Estimate of $496.25 million. With the consensus EPS estimate being $0.18, the EPS surprise was +11.11%.While investors scrutinize revenue and earnings changes year-over-year and how they compare with Wall Street expectations t ...

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended March 31, 2024 (State or other jurisdiction of Incorporation or organization) 1301 Concord Terrace Sunrise, Florida 33323 (Address of principal executive offices) (Zip Code) Florida 26-3667538 (I.R.S. Employer Identification No.) (954) 384-0175 (Registrant's telephone number, including area code) OR ☐ TRANSI ...

FOR MORE INFORMATION: Charles Lynch Senior Vice President, Finance and Strategy 954-384-0175, x 5692 charles.lynch@pediatrix.com FOR IMMEDIATE RELEASE Pediatrix Medical Group Reports First Quarter Results FORT LAUDERDALE, Fla., May 7, 2024 - Pediatrix Medical Group, Inc. (NYSE: MD), the nation's leading provider of highly specialized health care for women, children and babies, today reported earnings of $0.05 per share for the three months ended March 31, 2024. On a non-GAAP basis, Pediatrix reported Adjust ...

Pediatrix Medical Group, Inc. (NYSE:MD) Q4 2023 Results Conference Call February 20, 2024 9:00 AM ET Company Participants Charles Lynch - SVP, Finance & Strategy Jim Swift - CEO Marc Richards - CFO Conference Call Participants Jack Senft - William Blair Pito Chickering - Deutsche Bank Brian Tanquilut - Jefferies Kevin Fischbeck - Bank of America Operator Ladies and gentlemen, thank you for standing by. Welcome to the 2023 Fourth Quarter Earnings Conference Call. [Operator Instructions]. As a reminder, this ...

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 10-K ☒ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2023 ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the period from to Commission file number 001-12111 Pediatrix Medical Group, Inc. (Exact name of registrant as specified in its charter) FLORIDA 26-3667538 (State or other jurisdiction (I.R.S. Employer of ...